AG

Aparna Goyal

Active Director Director DIN 09706443
DIN 09706443 First appointment Aug 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Aparna Goyal

Data last updated:

Aparna Goyal is a Director at Alwaiswin Pharma India Private Limited (since 2022). The company operates in Chemicals. Alwaiswin Pharma India Private Limited reported revenue of ₹67.9 Lakh (FY 2025).

DIN 09706443
Primary Designation Director
Industry Chemicals
First Appointment 17 Aug 2022
Oldest Company Age 4 yrs
Largest company Alwaiswin Pharma India Private Limited · ₹67.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 20222022₹67.9 Lakh (FY 2025)Active

Board colleagues of Aparna Goyal

NameDINCompanyDesignation
Pardeep Goyal09706442Alwaiswin Pharma India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alwaiswin Pharma India Private Limited
Premium access

Shareholding and investment profile for Aparna Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aparna Goyal

Aparna Goyal currently holds 1 directorship: Alwaiswin Pharma India Private Limited (Director, since 17 Aug 2022, revenue ₹67.9 Lakh (FY 2025)).

Aparna Goyal was first appointed on 17 Aug 2022 as Director at Alwaiswin Pharma India Private Limited.

The current boards of Aparna Goyal's companies include Pardeep Goyal (Alwaiswin Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available